Zoya A. Goncharova

Rostov-na-donu, ROS, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis

Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 08, 2025

Hemorrhagic transformation following a malignant middle cerebral artery infarction.

Hemorrhagic transformation following a malignant middle cerebral artery infarction.

Journal: Journal of cerebrovascular and endovascular neurosurgery

Published: May 02, 2025

The difficulties with diagnostics of the stiff man syndrome

The difficulties with diagnostics of the stiff man syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: November 22, 2024

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 27, 2024

Treatment of patients with ishemic stroke in the vertebral-basilar system in acute period: experience of using the neuroprotective drug Mexidol

Treatment of patients with ishemic stroke in the vertebral-basilar system in acute period: experience of using the neuroprotective drug Mexidol

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: March 11, 2024

Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population

Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: October 05, 2023

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 10, 2023

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 21, 2023

Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results

Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: February 27, 2023

Association of the structure of the glucocorticoid receptor and single nucleotide NR3C1 gene polymorphisms with metabolic disorders

Association of the structure of the glucocorticoid receptor and single nucleotide NR3C1 gene polymorphisms with metabolic disorders

Journal: Problemy endokrinologii

Published: August 05, 2022

New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»)

New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 01, 2022

How I do it: decompressive hemicraniectomy supplemented with resection of the temporal pole and tentoriotomy for malignant ischemic infarction in the territory supplied by the middle cerebral artery.

How I do it: decompressive hemicraniectomy supplemented with resection of the temporal pole and tentoriotomy for malignant ischemic infarction in the territory supplied by the middle cerebral artery.

Journal: Acta neurochirurgica

Published: November 09, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026